Rui Zhao

7PUBLICATIONS
48CO-AUTHORS
AutoimmunityHaematological tumoursRespiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical virology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jun 19, 2026
Diffuse large B-cell lymphoma masquerading as multiple myeloma.

|Jun 17, 2026
Outcome of treatment with trametinib in adults with histiocytic neoplasms in the United Kingdom.

|Sep 12, 2024
Outcomes with single-agent gilteritinib for relapsed or refractory FLT3-mutant AML after contemporary induction therapy.

Jad Othman, Angela Hwang, Maximillian Brodermann

|Jul 08, 2024
CREST-UK: Real-world effectiveness, safety and outpatient delivery of CPX-351 for first-line treatment of newly diagnosed therapy-related AML and AML with myelodysplasia-related changes in the UK.

Priyanka Mehta, Victoria Campbell, Jamie Maddox

|Dec 21, 2023
Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study.

Ann Tivey, Rohan Shotton, Toby A Eyre

|Aug 30, 2023
Molecular MRD is strongly prognostic in patients with NPM1-mutated AML receiving venetoclax-based nonintensive therapy.

Jad Othman, Ing S Tiong, Jenny O'Nions

Pageof 2

Frequent Collaborators

4 joint publications

Anjum Khan

2 joint publications

Justin Loke

2 joint publications

Jenny O'Nions

2 joint publications

Jamie Maddox